Catalyst Wire Dossier Catalyst Wire Dossier

KPL-914

KPL-914 · Kiniksa Pharmaceuticals (UK), Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KPL-914, covering 2021-05-27 to 2021-05-27. Get the full timeline:

Most recent: Clinical Trial Update: A Pilot Study of KPL-914 in Recurrent Pericarditis [Phase 2]

See pricing